Cargando…

Bone mineral density is within normal range in most adult phenylketonuria patients

Low bone mineral density (BMD) as a risk factor for fractures has been a long‐standing concern in phenylketonuria (PKU). It is hypothesised that the disease itself or the dietary treatment might lead to a low BMD. Previous studies show conflicting results of BMD in PKU due to differences in age, tec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lubout, Charlotte M. A., Blanco, Francisco Arrieta, Bartosiewicz, Katarzyna, Feillet, François, Gizewska, Maria, Hollak, Carla, van der Lee, Johanna H., Maillot, François, Stepien, Karolina M., Wagenmakers, Margreet A. E. M., Welsink‐Karssies, Mendy M., van Spronsen, Francjan J., Bosch, Annet M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078943/ https://www.ncbi.nlm.nih.gov/pubmed/31587319 http://dx.doi.org/10.1002/jimd.12177

Ejemplares similares

Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results
por: Giżewska, Maria, et al.
Publicado: (2015)

The neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?
por: Anjema, Karen, et al.
Publicado: (2016)

Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype
por: Anjema, Karen, et al.
Publicado: (2013)

The complete European guidelines on phenylketonuria: diagnosis and treatment
por: van Wegberg, A. M. J., et al.
Publicado: (2017)

Cognitive functioning in patients with classical galactosemia: a systematic review
por: Hermans, Merel E., et al.
Publicado: (2019)

Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients
por: van Vliet, Kimber, et al.
Publicado: (2019)

Parenting a child with phenylketonuria or galactosemia: implications for health-related quality of life
por: ten Hoedt, Amber E., et al.
Publicado: (2011)

Sleep Disturbances in Phenylketonuria: An Explorative Study in Men and Mice
por: Bruinenberg, Vibeke M., et al.
Publicado: (2017)

Clinical pathways for inborn errors of metabolism: warranted and feasible
por: Demirdas, Serwet, et al.
Publicado: (2013)

Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study
por: Jahja, Rianne, et al.
Publicado: (2016)

Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study
por: Jahja, Rianne, et al.
Publicado: (2017)

Bone health in phenylketonuria: a systematic review and meta-analysis
por: Demirdas, Serwet, et al.
Publicado: (2015)

Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria
por: MacDonald, Anita, et al.
Publicado: (2018)

Correction to: Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities
por: Welsink-Karssies, Mendy M., et al.
Publicado: (2020)

Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities
por: Welsink-Karssies, Mendy M., et al.
Publicado: (2020)

The Behavioral Consequence of Phenylketonuria in Mice Depends on the Genetic Background
por: Bruinenberg, Vibeke M., et al.
Publicado: (2016)

Monitoring phenylalanine concentrations in the follow‐up of phenylketonuria patients: An inventory of pre‐analytical and analytical variation
por: Coene, Karlien L. M., et al.
Publicado: (2020)

The 1‐(13)C galactose breath test in GALT deficient patients distinguishes NBS detected variant patients but does not predict outcome in classical phenotypes
por: Welsink‐Karssies, Mendy M., et al.
Publicado: (2020)

"MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trial
por: ten Hoedt, Amber E, et al.
Publicado: (2011)

Gut-Microbiome Composition in Response to Phenylketonuria Depends on Dietary Phenylalanine in BTBR Pah(enu2) Mice
por: van der Goot, Els, et al.
Publicado: (2022)

Communication of an Abnormal Metabolic New-Born Screening Result in The Netherlands: The Parental Perspective
por: Haitjema, Sietske, et al.
Publicado: (2022)

Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU)
por: Bruinenberg, Vibeke M., et al.
Publicado: (2019)

Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis
por: de Groot, Martijn J, et al.
Publicado: (2013)

A Specific Nutrient Combination Attenuates the Reduced Expression of PSD-95 in the Proximal Dendrites of Hippocampal Cell Body Layers in a Mouse Model of Phenylketonuria
por: Bruinenberg, Vibeke M., et al.
Publicado: (2016)

Acute exercise in treated phenylketonuria patients: Physical activity and biochemical response
por: Mazzola, Priscila Nicolao, et al.
Publicado: (2015)

High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial
por: ten Hoedt, Amber E., et al.
Publicado: (2010)

Reducing complexity: explaining inborn errors of metabolism and their treatment to children and adolescents
por: Zeltner, Nina A., et al.
Publicado: (2019)

Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice
por: van Vliet, Danique, et al.
Publicado: (2015)

Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria
por: Pinto, Alex, et al.
Publicado: (2019)

Deep phenotyping classical galactosemia: clinical outcomes and biochemical markers
por: Welsink-Karssies, Mendy M, et al.
Publicado: (2020)

Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients’ and parents’ quality of life: the phenylketonuria – quality of life (PKU-QOL) questionnaires
por: Regnault, Antoine, et al.
Publicado: (2015)

Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway
por: van Vliet, Kimber, et al.
Publicado: (2022)

Aspartame and Phenylketonuria: an analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France
por: Maler, Victor, et al.
Publicado: (2023)

Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1
por: van Ginkel, Willem G., et al.
Publicado: (2019)

Mild hyperphenylalaninemia: to treat or not to treat
por: van Spronsen, Francjan J.
Publicado: (2011)

Juvenile idiopathic arthritis: magnetic resonance imaging of the clinically unaffected knee
por: van Gulik, E. Charlotte, et al.
Publicado: (2018)

The Benefit of Large Neutral Amino Acid Supplementation to a Liberalized Phenylalanine-Restricted Diet in Adult Phenylketonuria Patients: Evidence from Adult Pah-Enu2 Mice
por: van Vliet, Danique, et al.
Publicado: (2019)

Genotype-phenotype associations in French patients with phenylketonuria and importance of genotype for full assessment of tetrahydrobiopterin responsiveness
por: Jeannesson-Thivisol, Elise, et al.
Publicado: (2015)

Is the Phenylalanine-Restricted Diet a Risk Factor for Overweight or Obesity in Patients with Phenylketonuria (PKU)? A Systematic Review and Meta-Analysis
por: Rodrigues, Catarina, et al.
Publicado: (2021)

Large neutral amino acids in the treatment of PKU: from theory to practice
por: van Spronsen, Francjan J., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_kgmvu85riomv1kj9rbvamvqrq6